(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease

Mod Probl Pharmacopsychiatry. 1983:19:170-6. doi: 10.1159/000407513.
No abstract available

MeSH terms

  • Aged
  • Drug Therapy, Combination
  • Female
  • Humans
  • Levodopa / therapeutic use*
  • Male
  • Movement Disorders / drug therapy
  • Parkinson Disease / drug therapy*
  • Phenethylamines / therapeutic use*
  • Selegiline / adverse effects
  • Selegiline / therapeutic use*

Substances

  • Phenethylamines
  • Selegiline
  • Levodopa